SIG
PACB icon

Senator Investment Group’s Pacific Biosciences PACB Stock Holding History

Senator Investment Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,250,000
Closed -$12.3M – 83
2023
Q4 		$12.3M Buy
+1,250,000
New +$10.2M 0.53% 50
2023
Q3 		– Sell
-1,000,000
Closed -$13.3M – 60
2023
Q2 		$13.3M Hold
1,000,000
– – 0.6% 43
2023
Q1 		$11.6M Hold
1,000,000
– – 0.63% 35
2022
Q4 		$8.18M Buy
+1,000,000
New +$8.62M 0.74% 35
2021
Q4 		– Sell
-550,000
Closed -$14.1M – 109
2021
Q3 		$14.1M Hold
550,000
– – 0.24% 72
2021
Q2 		$19.2M Buy
+550,000
New +$16M 0.37% 60

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Senator Investment Group's PACB Position: Q1 2024 in Review

Senator Investment Group sold out of Pacific Biosciences (PACB) in Q1 2024, closing a stake of 1,250,000 shares — an estimated $12.3M sold.

Senator Investment Group first reported a position in PACB in Q2 2021 and held it in 6 quarters. The position peaked at $19.2M in Q2 2021. 268 funds tracked by Wall St. Rank hold PACB as of Q1 2024.

  • Senator Investment Group reported no remaining Pacific Biosciences position as of Q1 2024 after selling out during the quarter.
  • Senator Investment Group sold 1,250,000 Pacific Biosciences shares in Q1 2024, an estimated $12.3M.
  • Senator Investment Group first reported a position in Pacific Biosciences in Q2 2021 and held it in 6 quarters.
  • Senator Investment Group's Pacific Biosciences position peaked at $19.2M in Q2 2021.
  • 268 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2024.

Based on Senator Investment Group's 13F filing for Q1 2024, filed 14 May 2024.